Marc Grasso

CIK: 0001748894

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)4 (57.1%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (42.9%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

KYTX

Kyverna Therapeutics, Inc.

Officer

ALEC

Alector, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (7 total)

KYTX
Kyverna Therapeutics, Inc.
Mar 13, 2026
Award(A)
Direct
10K shares-
KYTX
Kyverna Therapeutics, Inc.
Jun 30, 2025
Award(A)
Stock Option (right to buy)
Direct
450K shares-
ALEC
Alector, Inc.
Jun 2, 2025
Sale(S)
Direct
16.5K shares at avg. $1.34$22K
ALEC
Alector, Inc.
Mar 3, 2025
Sale(S)
Direct
18.1K shares at avg. $1.47$27K
ALEC
Alector, Inc.
Dec 2, 2024
Sale(S)
Direct
16.5K shares at avg. $2.52$42K
ALEC
Alector, Inc.
Oct 1, 2024
Award(A)
Direct
216.4K shares-
ALEC
Alector, Inc.
Sep 3, 2024
Sale(S)
Direct
7.3K shares at avg. $4.88$36K

		Type	Shares	Price		Ownership
Mar 13, 2026	KYTX Kyverna Therapeutics, Inc.	Award(A)	10,000	-	$0	Direct
Jun 30, 2025	KYTX Kyverna Therapeutics, Inc.	Award(A) Stock Option (right to buy)	450,000	-	-	Direct
Jun 2, 2025	ALEC Alector, Inc.	Sale(S)	16,488	$1.34	$22,068	Direct
Mar 3, 2025	ALEC Alector, Inc.	Sale(S)	18,091	$1.47	$26,547	Direct
Dec 2, 2024	ALEC Alector, Inc.	Sale(S)	16,489	$2.52	$41,542	Direct
Oct 1, 2024	ALEC Alector, Inc.	Award(A)	216,400	-	$0	Direct
Sep 3, 2024	ALEC Alector, Inc.	Sale(S)	7,297	$4.88	$35,620	Direct

1-7 of 7 transactions

About GRASSO MARC

GRASSO MARC (SEC CIK 0001748894) files insider reports with the SEC as Chief Financial Officer of Kyverna Therapeutics, Inc. (KYTX) and Chief Financial Officer of Alector, Inc. (ALEC).

Signal8 holds 8 ownership filings by GRASSO MARC (1 Form 3, 7 Form 4), filed between Sep 4, 2024 and Mar 17, 2026. Those filings report 7 transactions, from Sep 3, 2024 to Mar 13, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on GRASSO MARC's filings is in EMERYVILLE, CA.

Recent filings by GRASSO MARC

Mar 13, 2026: Grant or award of KYTX shares (Form 4, code A).
Jun 30, 2025: Grant or award of KYTX derivative securities (Form 4, code A).
Jun 2, 2025: Open-market sale of ALEC shares (Form 4, code S).
Mar 3, 2025: Open-market sale of ALEC shares (Form 4, code S).
Dec 2, 2024: Open-market sale of ALEC shares (Form 4, code S).

Other insiders filing for Kyverna Therapeutics, Inc. (KYTX)

CLARK IAN T, Director
Cohen Fred E, Director
SEIDENBERG BETH C, Director
Shaw Christi, Executive Chairperson
Aktar Mert, Director
Martini Gregory S., Chief Financial Officer

How to read Form 4 transaction codes